The rapid emergence of resistance
against frontline antimalarial
drugs essentially warrants the identification of new-generation antimalarials.
Here, we describe the synthesis of (E)-2-isopropyl-5-methyl-4-((2-(pyridin-4-yl)hydrazono)methyl)phenol
(18), which binds ferriprotoporphyrin-IX (FeIII-PPIX) (Kd = 33 nM) and offers antimalarial
activity against chloroquine-resistant and sensitive strains of Plasmodium falciparum in vitro. Structure–function
analysis reveals that compound 18 binds FeIII-PPIX through the −CN–NH– moiety and
2-pyridyl substitution at the hydrazine counterpart plays a critical
role in antimalarial efficacy. Live cell confocal imaging using a
fluorophore-tagged compound confirms its accumulation inside the acidic
food vacuole (FV) of P. falciparum. Furthermore,
this compound concentration-dependently elevates the pH in FV, implicating
a plausible interference with FeIII-PPIX crystallization
(hemozoin formation) by a dual function: increasing the pH and binding
free FeIII-PPIX. Different off-target bioassays reduce
the possibility of the promiscuous nature of compound 18. Compound 18 also exhibits potent in vivo antimalarial
activity against chloroquine-resistant P. yoelii and P. berghei ANKA (causing cerebral malaria) in mice with
negligible toxicity.